Division of Net Royalty and Proceeds - Revision history

Mhurlocker: /* Additional Information */

2024-08-19T20:41:58Z

Additional Information

← Older revision		Revision as of 15:41, August 19, 2024
Line 71:		Line 71:
	*University of Nebraska Board of Regents [https://nebraska.edu/-/media/unca/docs/offices-and-policies/policies/board-governing-documents/board-of-regents-policies.pdf?la=en Policies]		*University of Nebraska Board of Regents [https://nebraska.edu/-/media/unca/docs/offices-and-policies/policies/board-governing-documents/board-of-regents-policies.pdf?la=en Policies]
	<br />		<br />
	This page maintained by [mailto:~~dpanowic~~@unmc.edu ~~dkp~~].		This page maintained by [mailto:mhurlocker@unmc.edu mh].

Dpanowic at 17:50, May 3, 2021

2021-05-03T17:50:31Z

← Older revision		Revision as of 12:50, May 3, 2021
Line 30:		Line 30:
	Policy No.: '''7001'''<br />		Policy No.: '''7001'''<br />
	Effective Date: '''03/16/05'''<br />		Effective Date: '''03/16/05'''<br />
	Revised Date: '''~~Draft~~'''<br />		Revised Date: '''05/03/21'''<br />
	Reviewed Date: '''~~Draft~~'''<br />		Reviewed Date: '''05/03/21'''<br />

	<big>'''Policy for Division of Net Royalty and Proceeds'''</big>		<big>'''Policy for Division of Net Royalty and Proceeds'''</big>

Dpanowic at 15:21, April 9, 2021

2021-04-09T15:21:09Z

← Older revision		Revision as of 10:21, April 9, 2021
Line 43:		Line 43:
	:b. Two-thirds in accordance with a separate distribution policy to be established and implemented by each University campus, such policy to take effect following approval by the Board of Regents upon recommendation of the relevant campus’ Chancellor.”		:b. Two-thirds in accordance with a separate distribution policy to be established and implemented by each University campus, such policy to take effect following approval by the Board of Regents upon recommendation of the relevant campus’ Chancellor.”
	== Policy ==		== Policy ==
	~~To implement~~ RP-4.4.2, ~~the following policy for the University of Nebraska Medical Center is proposed for~~ the distribution of royalties and other proceeds from the commercialization of technology. <br />		The University of Nebraska Medical Center implements this policy, consistent with RP-4.4.2, which outlines the distribution of royalties and other proceeds from the commercialization of technology. <br />

	1. To assure that the University is reimbursed for all costs associated with protecting and commercialization of the particular technology, the following expenses shall be recouped prior to any further distribution of proceeds from the technology:		1. To assure that the University is reimbursed for all costs associated with protecting and commercialization of the particular technology, the following expenses shall be recouped prior to any further distribution of proceeds from the technology:
Line 63:		Line 63:
	4. For inventions with inventors from multiple colleges/institutes, the individual college/institute portion will be proportional to the contribution of faculty agreed upon in section 2.a. above. <br />		4. For inventions with inventors from multiple colleges/institutes, the individual college/institute portion will be proportional to the contribution of faculty agreed upon in section 2.a. above. <br />

	5. For intercampus collaborative projects, intellectual property ~~(IP)~~ protection/prosecution efforts will be led by the campus with the majority interest in the invention. Net royalties will be divided between campuses based on their equity share in the IP and distribution of net royalties within each campus will be dictated by the relevant campus policy. <br />		5. For intercampus collaborative projects, intellectual property protection/prosecution efforts will be led by the campus with the majority interest in the invention. Net royalties will be divided between campuses based on their equity share in the intellectual property and distribution of net royalties within each campus will be dictated by the relevant campus policy. <br />

	6. If equity is taken in lieu of royalties that otherwise would be distributed under this policy, the equity will be held by UNeMed. Any dividends or proceeds from liquidation of the equity interest shall be distributed in accordance with this policy as though they were royalties.		6. If equity is taken in lieu of royalties that otherwise would be distributed under this policy, the equity will be held by UNeMed. Any dividends or proceeds from liquidation of the equity interest shall be distributed in accordance with this policy as though they were royalties.

Dpanowic at 20:33, April 8, 2021

2021-04-08T20:33:04Z

← Older revision		Revision as of 15:33, April 8, 2021
Line 68:		Line 68:
	==Additional Information==		==Additional Information==
	*Contact UNeMed or the [mailto:jnickla@unmc.edu Director, UNeMed]		*Contact UNeMed or the [mailto:jnickla@unmc.edu Director, UNeMed]
	*University of Nebraska Board of [https://~~www~~.~~researchgate.net~~/~~publication~~/~~332394709_RP~~-~~442_Patent_and_Technology_Transfer_Policy_University_of_Nebraska_Board_of_Regents_Policies~~ Regents ~~Policy 4~~.4.2]		*University of Nebraska Board of Regents [https://nebraska.edu/-/media/unca/docs/offices-and-policies/policies/board-governing-documents/board-of-regents-bylaws.pdf?la=en Bylaws]
			*University of Nebraska Board of Regents [https://nebraska.edu/-/media/unca/docs/offices-and-policies/policies/board-governing-documents/board-of-regents-policies.pdf?la=en Policies]
	<br />		<br />
	This page maintained by [mailto:dpanowic@unmc.edu dkp].		This page maintained by [mailto:dpanowic@unmc.edu dkp].

Dpanowic at 22:01, April 2, 2021

2021-04-02T22:01:20Z

← Older revision		Revision as of 17:01, April 2, 2021
Line 59:		Line 59:
	:d. The remaining proceeds will be distributed to the UNMC Chancellor’s office to enhance the services of the technology development office to support services to faculty in the filing of disclosure, protection of intellectual property and the marketing, licensing and commercialization of technologies. A portion of these funds may be used for grants to develop prototypes and conduct additional research to facilitate commercialization of technologies. <br />		:d. The remaining proceeds will be distributed to the UNMC Chancellor’s office to enhance the services of the technology development office to support services to faculty in the filing of disclosure, protection of intellectual property and the marketing, licensing and commercialization of technologies. A portion of these funds may be used for grants to develop prototypes and conduct additional research to facilitate commercialization of technologies. <br />

	3. The UNMC Chancellor’s office may enter into agreements with third parties which modify the distribution of non-inventor net proceeds described in paragraph 2 subparts b, c and d. Any such modification shall be presented to the UNMC Research Resources Board or its functional equivalent. <br />		3. The UNMC Chancellor’s office may enter into agreements with third parties which modify the distribution of non-inventor net proceeds described in paragraph 2 subparts b, c and d. Any such modification shall be presented to the UNMC Research Resources Board or its functional equivalent. <br />

	4. For inventions with inventors from multiple colleges/institutes, the individual college/institute portion will be proportional to the contribution of faculty agreed upon in section 2.a, above. <br />		4. For inventions with inventors from multiple colleges/institutes, the individual college/institute portion will be proportional to the contribution of faculty agreed upon in section 2.a. above. <br />

	5. For intercampus collaborative projects, IP protection/prosecution efforts will be led by the campus with the majority interest in the invention. Net royalties will be divided between campuses based on their equity share in the IP and distribution of net royalties within each campus will be dictated by the relevant campus policy. <br />		5. For intercampus collaborative projects, intellectual property (IP) protection/prosecution efforts will be led by the campus with the majority interest in the invention. Net royalties will be divided between campuses based on their equity share in the IP and distribution of net royalties within each campus will be dictated by the relevant campus policy. <br />

	6. If equity is taken in lieu of royalties that otherwise would be distributed under this policy, the equity will be held by UNeMed. Any dividends or proceeds from liquidation of the equity interest shall be distributed in accordance with this policy as though they were royalties.		6. If equity is taken in lieu of royalties that otherwise would be distributed under this policy, the equity will be held by UNeMed. Any dividends or proceeds from liquidation of the equity interest shall be distributed in accordance with this policy as though they were royalties.

Dpanowic at 20:39, April 2, 2021

2021-04-02T20:39:59Z

← Older revision		Revision as of 15:39, April 2, 2021
Line 31:		Line 31:
	Effective Date: '''03/16/05'''<br />		Effective Date: '''03/16/05'''<br />
	Revised Date: '''Draft'''<br />		Revised Date: '''Draft'''<br />
	Reviewed Date: '''Draft'''~~<br />~~<br />		Reviewed Date: '''Draft'''<br />

	<big>'''Policy for Division of Net Royalty and Proceeds'''</big>		<big>'''Policy for Division of Net Royalty and Proceeds'''</big>
	~~<br /><br />~~
	== Basis for Policy ==		== Basis for Policy ==
			Section 5 of the RP-4.4.2 Regents’ Patent and Technology Transfer Policy includes information on the division of net royalties and proceeds: <br />

	~~== Membership ==~~		“With respect to any invention subject to this Policy, the University shall first be reimbursed for any and all expenses incurred by it that are associated with evaluation of the technology, obtaining of patent or other intellectual property protection, and licensing or other technology transfer activity, including legal expenses related thereto. In the event of any infringement action or other legal action involving technology disclosed under this Policy, the University shall also be reimbursed for any and all expenses borne by the University associated with such action. After such expenses are reimbursed, royalties and other proceeds from licenses or other technology transfer activities related to an invention, or patent or other intellectual property protection based thereon, shall be distributed as follows: <br />
	~~Members of~~ the ~~Committee for Proceed Distribution~~ shall be ~~the Vice Chancellor~~ for ~~Business~~ and ~~Finance,~~ the ~~Vice Chancellor for Research~~, ~~the Vice Chancellor~~ of ~~Academic Affairs~~, the ~~President~~ of ~~UNeMed~~, the ~~Patent Administrator~~ and ~~one member at large~~ to be ~~selected annually by~~ a ~~majority vote of~~ the ~~other members~~. ~~The Committee shall meet at least annually~~ to ~~carry out~~ the ~~function~~ of RP- 4.4.2, ~~Section 5(b).~~
	~~==Responsibilities==~~		:a. One-third to the inventor or inventors; and <br />
	* Expenses and Net Proceeds
	~~:* Reviewing~~ the ~~legal fees~~ and other technology ~~transfer expenses associated with each source of proceeds. Regents’ Policy requires that such expenses be reimbursed before any proceed distributions are made~~. <br />		:b. Two-thirds in accordance with a separate distribution policy to be established and implemented by each University campus, such policy to take effect following approval by the Board of Regents upon recommendation of the relevant campus’ Chancellor.”
	::To ~~meet this requirement 10%~~ of ~~all proceeds received will be set aside for~~ the ~~administration of~~ technology ~~transfer. In addition~~, ~~patent~~ expenses ~~and other legal and professional expenses will first~~ be ~~reimbursed~~ from ~~gross proceeds.~~		== Policy ==
	:* Reviewing general proceed allocations with other organizations and ~~non-inventor proceed allocations between campuses~~.		To implement RP-4.4.2, the following policy for the University of Nebraska Medical Center is proposed for the distribution of royalties and other proceeds from the commercialization of technology. <br />
	* Distribution of Net Proceeds to Inventors
	:* Ensuring that with respect to proceeds covered by ~~Regents’ Policies~~, ~~one third~~ of ~~all net proceeds received by~~ the ~~University is distributed~~ to ~~University~~ of ~~Nebraska~~ inventors.		1. To assure that the University is reimbursed for all costs associated with protecting and commercialization of the particular technology, the following expenses shall be recouped prior to any further distribution of proceeds from the technology:
	::~~When~~ a ~~single source of proceeds involves multiple University of Nebraska~~ inventors, inventors ~~should coordinate with UNeMed~~ to ~~file a written agreement delineating~~ the ~~division~~ of ~~proceeds between all~~ inventors. ~~Multiple inventor~~ proceeds ~~received but not adequately covered by a written inventor agreement~~ will be distributed equally ~~between~~ all ~~University of Nebraska~~ inventors.		:a. Any funding provided to inventors or creators by UNMC, the University of Nebraska, UNeTech or UNeMed for research and development or for facilitating commercialization of research. <br />
	:* In some highly meritorious cases a given inventor may be found to have earned a share of the proceeds ~~that exceeds the general recommendation of one-third; however in no case~~ will ~~a distribution~~ be ~~made to an inventor that exceeds~~ the ~~recommended one-third until the university has recovered 100 percent of its costs, and an appropriate continuing share has been determined for the university~~. Such ~~decisions are to~~ be ~~considered highly exceptional and will require the approval of the President upon recommendation of the Chancellor. The President shall report such exceptions~~ to the ~~Board of Regents~~.
	* Distribution of Net Proceeds to Non-inventors		:b. All out-of-pocket direct expenses incurred by UNMC or UNeMed in protecting, maintaining, defending and commercialization of the technology. On technologies with guaranteed annual minimum royalties, out-of-pocket expenses may be allocated over several years to facilitate immediate payment of royalties to inventors. <br />
	:* Examining sources of net ~~non-inventor proceeds covered by~~ the ~~Regents’ intellectual property policies and determining what proportion, if any, should~~ be distributed to ~~inventors’ academic/administrative units. This determination shall be in keeping with each unit’s level of~~ support and ~~commitment to technology development~~. ~~Academic/administrative units found~~ to ~~be without significant~~ contribution to ~~technology development may be excluded from receiving proceeds~~.		2. After the deductions authorized by paragraph 1, the remaining net proceeds from the commercialization of the technology shall be distributed as follows: <br />
	~~::Deans~~ or ~~Directors~~ of ~~the academic~~/~~administrative units employing faculty or other persons responsible for creating intellectual property from which net~~ proceeds ~~are generated shall~~ be ~~given notice of Committee meetings and provided~~ the ~~opportunity~~ to ~~present information representing significant support~~ of ~~UNMC~~ technology development~~. Ordinary~~ support ~~consisting~~ of ~~only~~ the ~~usual salary, space~~, and ~~equipment afforded to faculty shall not be considered significant~~. ~~Information intended to be representative~~ of significant support to technology development shall be substantiated through documentation, interviews with inventors, or other appropriate means. The Committee shall refrain from deciding non-inventor proceed allocations until all interested principals have been given reasonable opportunity to participate.
	~~:* Earmarking net proceeds as~~ may ~~be distributed to academic/administrative units to~~ be used for research ~~beneficial~~ to ~~technology development~~.		:a. One-third will be distributed to the inventors pursuant to RP 4.4.2. Royalties will be distributed among all inventors based on their relative contributions to the development of the invention and should be agreed upon by inventors prior to the distribution. If no agreement exists, royalties and proceeds will be distributed equally among all inventors.<br />
	~~:* Allocating any net non-inventor proceeds to~~ UNMC ~~accounts for use in furthering translational research or otherwise furthering~~ the ~~objectives~~ of ~~technology and economic development. This includes those net~~ non-inventor proceeds ~~not distributed to academic/administrative units~~.
	~~:* The allocation and/or earmarking of net non-inventor proceeds not to~~ be ~~distributed to any academic/administrative units shall take the form of a recommendation made~~ to the UNMC Research Resources Board or its functional equivalent. ~~The Research Resources Board shall then confirm or redirect~~ the ~~non-unit distribution and report~~ the ~~final recommendation to UNMC’s Chancellor before such proceeds are made available~~.		:b. A technology management fee of 15% of the proceeds will be charged as overhead associated with the technology. Such overhead shall be used to support the administrative costs associated with UNeMed. <br />
	* Other Responsibilities
	~~:* Performing other responsibilities~~ within the ~~scope of RP- 4~~.4.2, ~~Section 5(b)~~.		:c. Ten percent of the net royalties up to the first $2 million of cumulative annual UNMC royalties will be transferred to a fund that will be distributed to the College(s) or Institute(s) to support and enhance research. The royalties will be distributed to the Colleges based on their proportional contribution to the fund. College(s) or Institute(s) share will increase to 20% of net cumulative annual UNMC royalties over $2 million. <br />

			:d. The remaining proceeds will be distributed to the UNMC Chancellor’s office to enhance the services of the technology development office to support services to faculty in the filing of disclosure, protection of intellectual property and the marketing, licensing and commercialization of technologies. A portion of these funds may be used for grants to develop prototypes and conduct additional research to facilitate commercialization of technologies. <br />

			3. The UNMC Chancellor’s office may enter into agreements with third parties which modify the distribution of non-inventor net proceeds described in paragraph 2 subparts b, c and d. Any such modification shall be presented to the UNMC Research Resources Board or its functional equivalent. <br />

			4. For inventions with inventors from multiple colleges/institutes, the individual college/institute portion will be proportional to the contribution of faculty agreed upon in section 2.a, above. <br />

			5. For intercampus collaborative projects, IP protection/prosecution efforts will be led by the campus with the majority interest in the invention. Net royalties will be divided between campuses based on their equity share in the IP and distribution of net royalties within each campus will be dictated by the relevant campus policy. <br />

			6. If equity is taken in lieu of royalties that otherwise would be distributed under this policy, the equity will be held by UNeMed. Any dividends or proceeds from liquidation of the equity interest shall be distributed in accordance with this policy as though they were royalties.
	==Additional Information==		==Additional Information==
	*Contact UNeMed or the [mailto:jnickla@unmc.edu Director, UNeMed]		*Contact UNeMed or the [mailto:jnickla@unmc.edu Director, UNeMed]
	*University of Nebraska Board of [https://~~nebraska~~.~~edu~~/-/~~media/unca/docs/offices~~-~~and-policies/policies/board-governing-documents/board-of-regents-policies.pdf?la=en~~ Regents Policy]		*University of Nebraska Board of [https://www.researchgate.net/publication/332394709_RP-442_Patent_and_Technology_Transfer_Policy_University_of_Nebraska_Board_of_Regents_Policies Regents Policy 4.4.2]
	<br />		<br />
	This page maintained by [mailto:dpanowic@unmc.edu dkp].		This page maintained by [mailto:dpanowic@unmc.edu dkp].

Dpanowic at 19:59, April 2, 2021

2021-04-02T19:59:02Z

← Older revision		Revision as of 14:59, April 2, 2021
Line 26:		Line 26:
	</table>		</table>
	<br />		<br />
	[[Science/Technology Committee]] \| [[Royalty~~/Equity Distribution~~]]		[[Science/Technology Committee]] \| [[Division of Net Royalty and Proceeds]]
	<br /><br />		<br /><br />
	Policy No.: '''7001'''<br />		Policy No.: '''7001'''<br />
	Effective Date: '''03/16/05'''<br />		Effective Date: '''03/16/05'''<br />
	Revised Date: '''~~02/10/10~~'''<br />		Revised Date: '''Draft'''<br />
	Reviewed Date: '''~~09/20/13~~'''<br /><br />		Reviewed Date: '''Draft'''<br /><br />

	<big>'''Policy for Royalty and ~~Equity Distribution~~'''</big>		<big>'''Policy for Division of Net Royalty and Proceeds'''</big>
	<br /><br />		<br /><br />
	== Basis for Policy ==		== Basis for Policy ==
	As per RP-4.4.2 Board of Regents Patent and Technology Transfer Policy, the University of Nebraska Medical Center (UNMC) is responsible for allocating non-inventor technology transfer proceeds according to its individual campus policy. These non-inventor proceeds consist of two thirds of the royalties and equity received in return for use of University owned intellectual property rights. Furthermore, University of Nebraska Board of [https://nebraska.edu/-/media/unca/docs/offices-and-policies/policies/board-governing-documents/board-of-regents-policies.pdf Regents Policy] no longer requires that a share of proceeds be distributed to the academic/administrative units of inventors. In order to best utilize non-inventor proceeds and to serve the objectives of the Regents Policy, UNMC shall allocate non-inventor proceeds on a case by case basis as determined by the Committee for Proceed Distribution. Those academic/administrative units having a connection to proceeds at issue shall participate to provide the Committee with information addressing their support of the underlying technology.
	== Membership ==		== Membership ==
	Members of the Committee for Proceed Distribution shall be the Vice Chancellor for Business and Finance, the Vice Chancellor for Research, the Vice Chancellor of Academic Affairs, the President of UNeMed, the Patent Administrator and one member at large to be selected annually by a majority vote of the other members. The Committee shall meet at least annually to carry out the function of RP- 4.4.2, Section 5(b).		Members of the Committee for Proceed Distribution shall be the Vice Chancellor for Business and Finance, the Vice Chancellor for Research, the Vice Chancellor of Academic Affairs, the President of UNeMed, the Patent Administrator and one member at large to be selected annually by a majority vote of the other members. The Committee shall meet at least annually to carry out the function of RP- 4.4.2, Section 5(b).

Dpanowic: Dpanowic moved page Royalty/Equity Distribution to Division of Net Royalty and Proceeds: Policy Revision

2021-04-02T19:56:36Z

Dpanowic moved page Royalty/Equity Distribution to Division of Net Royalty and Proceeds: Policy Revision

← Older revision	Revision as of 14:56, April 2, 2021
(No difference)

Daniel.carlson: Updated broken links

2020-02-20T14:38:21Z

Updated broken links

← Older revision		Revision as of 09:38, February 20, 2020
Line 36:		Line 36:
	<br /><br />		<br /><br />
	== Basis for Policy ==		== Basis for Policy ==
	As per RP-4.4.2 Board of Regents Patent and Technology Transfer Policy, the University of Nebraska Medical Center (UNMC) is responsible for allocating non-inventor technology transfer proceeds according to its individual campus policy. These non-inventor proceeds consist of two thirds of the royalties and equity received in return for use of University owned intellectual property rights. Furthermore, University of Nebraska Board of [~~http~~://nebraska.edu/docs/board/~~RegentPolicies~~.pdf Regents Policy] no longer requires that a share of proceeds be distributed to the academic/administrative units of inventors. In order to best utilize non-inventor proceeds and to serve the objectives of the Regents Policy, UNMC shall allocate non-inventor proceeds on a case by case basis as determined by the Committee for Proceed Distribution. Those academic/administrative units having a connection to proceeds at issue shall participate to provide the Committee with information addressing their support of the underlying technology.		As per RP-4.4.2 Board of Regents Patent and Technology Transfer Policy, the University of Nebraska Medical Center (UNMC) is responsible for allocating non-inventor technology transfer proceeds according to its individual campus policy. These non-inventor proceeds consist of two thirds of the royalties and equity received in return for use of University owned intellectual property rights. Furthermore, University of Nebraska Board of [https://nebraska.edu/-/media/unca/docs/offices-and-policies/policies/board-governing-documents/board-of-regents-policies.pdf Regents Policy] no longer requires that a share of proceeds be distributed to the academic/administrative units of inventors. In order to best utilize non-inventor proceeds and to serve the objectives of the Regents Policy, UNMC shall allocate non-inventor proceeds on a case by case basis as determined by the Committee for Proceed Distribution. Those academic/administrative units having a connection to proceeds at issue shall participate to provide the Committee with information addressing their support of the underlying technology.
	== Membership ==		== Membership ==
	Members of the Committee for Proceed Distribution shall be the Vice Chancellor for Business and Finance, the Vice Chancellor for Research, the Vice Chancellor of Academic Affairs, the President of UNeMed, the Patent Administrator and one member at large to be selected annually by a majority vote of the other members. The Committee shall meet at least annually to carry out the function of RP- 4.4.2, Section 5(b).		Members of the Committee for Proceed Distribution shall be the Vice Chancellor for Business and Finance, the Vice Chancellor for Research, the Vice Chancellor of Academic Affairs, the President of UNeMed, the Patent Administrator and one member at large to be selected annually by a majority vote of the other members. The Committee shall meet at least annually to carry out the function of RP- 4.4.2, Section 5(b).

Dpanowic at 18:38, July 26, 2019

2019-07-26T18:38:17Z

← Older revision		Revision as of 13:38, July 26, 2019
Line 36:		Line 36:
	<br /><br />		<br /><br />
	== Basis for Policy ==		== Basis for Policy ==
	As per RP-4.4.2 Board of Regents Patent and Technology Transfer Policy, the University of Nebraska Medical Center (UNMC) is responsible for allocating non-inventor technology transfer proceeds according to its individual campus policy. These non-inventor proceeds consist of two thirds of the royalties and equity received in return for use of University owned intellectual property rights. Furthermore, [http://nebraska.edu/docs/board/RegentPolicies.pdf Regents Policy] no longer requires that a share of proceeds be distributed to the academic/administrative units of inventors. In order to best utilize non-inventor proceeds and to serve the objectives of the Regents Policy, UNMC shall allocate non-inventor proceeds on a case by case basis as determined by the Committee for Proceed Distribution. Those academic/administrative units having a connection to proceeds at issue shall participate to provide the Committee with information addressing their support of the underlying technology.		As per RP-4.4.2 Board of Regents Patent and Technology Transfer Policy, the University of Nebraska Medical Center (UNMC) is responsible for allocating non-inventor technology transfer proceeds according to its individual campus policy. These non-inventor proceeds consist of two thirds of the royalties and equity received in return for use of University owned intellectual property rights. Furthermore, University of Nebraska Board of [http://nebraska.edu/docs/board/RegentPolicies.pdf Regents Policy] no longer requires that a share of proceeds be distributed to the academic/administrative units of inventors. In order to best utilize non-inventor proceeds and to serve the objectives of the Regents Policy, UNMC shall allocate non-inventor proceeds on a case by case basis as determined by the Committee for Proceed Distribution. Those academic/administrative units having a connection to proceeds at issue shall participate to provide the Committee with information addressing their support of the underlying technology.
	== Membership ==		== Membership ==
	Members of the Committee for Proceed Distribution shall be the Vice Chancellor for Business and Finance, the Vice Chancellor for Research, the Vice Chancellor of Academic Affairs, the President of UNeMed, the Patent Administrator and one member at large to be selected annually by a majority vote of the other members. The Committee shall meet at least annually to carry out the function of RP- 4.4.2, Section 5(b).		Members of the Committee for Proceed Distribution shall be the Vice Chancellor for Business and Finance, the Vice Chancellor for Research, the Vice Chancellor of Academic Affairs, the President of UNeMed, the Patent Administrator and one member at large to be selected annually by a majority vote of the other members. The Committee shall meet at least annually to carry out the function of RP- 4.4.2, Section 5(b).
Line 57:		Line 57:
	:* Performing other responsibilities within the scope of RP- 4.4.2, Section 5(b).		:* Performing other responsibilities within the scope of RP- 4.4.2, Section 5(b).
	==Additional Information==		==Additional Information==
	*Contact UNeMed or the [mailto:jnickla@unmc.edu ~~UNMC Patent Administrator~~]		*Contact UNeMed or the [mailto:jnickla@unmc.edu Director, UNeMed]
	*[~~http~~://nebraska.edu/docs/board/~~RegentPolicies~~.pdf ~~University of Nebraska Board of~~ Regents ~~Policies~~]<br />		*University of Nebraska Board of [https://nebraska.edu/-/media/unca/docs/offices-and-policies/policies/board-governing-documents/board-of-regents-policies.pdf?la=en Regents Policy]
			<br />
	This page maintained by [mailto:dpanowic@unmc.edu dkp].		This page maintained by [mailto:dpanowic@unmc.edu dkp].